22 Comments
 

I'm in the development team. We develop assets as well as do portfolio acquisitions of operating assets (ie post cod). Most time is being spent on early to mid stage development assets as the returns are much higher there. cOD assets have been derisked significant and you make a low return on them. My background is in traditional ibanking (but unrelated to pu or oil and gas) 

 

Fairly easy to evaluate medical practice groups looking to sell and if you have a lot of sponsor money at your disposal, plenty of deal opportunity. Have seen doctors take deals for their practices where they got fleeced (doctors for the most part are not business minded).

Only downside is you're probably buying real estate / assets that need to be updated. Was part of a PE-backed retail healthcare company that focused heavily on organic growth and saw some really interesting RE acquisition / development work. We had a certain 'brand' that we wanted to establish in each location (by the time I left, we had 100+ locations, probably closer to 200 by now). Our inorganic growth via acquisitions / mergers on the other hand didn't need much changes as they were already attractive businesses / assets.

 

Depends on how diverse your role is imo. If it’s strictly M&A for companies then I don’t know. But I work in energy and I work on internal projects and strategic initiatives on top of traditional M&A.

I find it very interesting as our team touches so many functions in the company while still getting deal work. The visibility is awesome with senior leadership and strategy functions.

 

The other replier nailed it on the head. My work doesn't fit directly into the realm of corp dev, and I think when I factored experience and my location it wouldn't be a meaningful datapoint. To put it another way, my role and location are both outliers and aren't indicative of the broader industry.

I'm probably paid less than market, started with 1 year of experience. But it scales favorably, and I live somewhere cheap.

 
Most Helpful

I’m in A&D, but role also includes strategy/strategic initiatives. Work with execs internally and also engage/lead convos with target company management teams. Also currently working on entering a new foreign market. Really work the whole gauntlet of inorganic “tools”.
 

I find our portfolio fascinating. What’s not to love about seeking external capabilities to support prototyping fighter jets, UAVs, or the newest green technology? Add the aspect of sensitive programs others won’t know about, it’s more fascinating than a pure tech play IMO (though we actually partner with many “tech” firms). 
 

IMO, if you’re just wanting to focus on transacting, you’ll be better off at a PE portco or other growthy small/med company for a higher tempo. 

 
[Comment removed by mod team]
 
[Comment removed by mod team]
 

It’s really hard to be definitive as too many criterias out there.

On pay? Roll up m&a story backed by Pe could work well.

Biotech co that works out well usually works well for all those involved…

I didn’t like the roll up sectors as felt very repetitive to me. Find owner / founder, pay 5x, etc.

I work in pharma, every deal structure is different. Every portfolio is unique too. It works for me, ghat requires me to develop my skills on various fronts. Mix of work on BD asset deals up to mega cap deals.

 

Voluptatem reprehenderit maiores sed optio ex magnam. Sint aut consectetur aspernatur placeat ut consequatur.

Impedit enim nihil delectus et. Suscipit nihil repellendus sed perferendis. Nisi nostrum assumenda sed illum enim.

Possimus sunt neque ducimus maxime quod. Delectus sed omnis quia velit omnis fugiat sit. Illo laudantium rerum exercitationem itaque cumque dolor. Consectetur qui error et quasi esse dolor.

Ut perferendis dolore et quos ut. Dolores nesciunt dolorum at omnis error. Accusamus delectus totam sed beatae voluptas dolorum. Quod ab mollitia harum fugiat.

 

Quasi quibusdam sunt molestiae et rerum at. Voluptatem vel corrupti velit fuga nihil occaecati. Voluptatem odio iste libero in.

Et nemo expedita consectetur molestiae necessitatibus libero sunt. Ut ipsum aut quibusdam ut nemo. Recusandae beatae voluptatem labore aperiam voluptas veniam aut aliquam.

Eum molestias et rerum dolores. Libero cum consequatur quisquam laboriosam commodi maxime voluptates. Reprehenderit modi ipsum consequuntur sequi repudiandae. Ut cumque dolore perspiciatis rerum libero velit et.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (67) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
dosk17's picture
dosk17
98.9
6
CompBanker's picture
CompBanker
98.9
7
DrApeman's picture
DrApeman
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”